LITESPARK-012: pembrolizumab plus lenvatinib with or without belzutifan or quavonlimab for advanced renal cell carcinoma
Future Oncology, Ahead of Print.
Source: Future Oncology - Category: Cancer & Oncology Authors: Toni K Choueiri Thomas Powles Martin H Voss Elizabeth R Plimack Howard Gurney Yue Song Rodolfo F Perini Karla Rodriguez-Lopez Brian I Rini Source Type: research